Aptamer-based biosensor for simultaneous detection of thrombin and von Willebrand factor in plasma.
2016/21/N/NZ5/01439
Keywords
Descriptors
- NZ5_5: Diagnostyka chorób człowieka
- NZ5_6: Diagnostyka chorób zwierząt
- ST5_9: Materiały do konstrukcji sensorów
Panel
NZ5 – Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution
Uniwersytet Jagielloński, Jagiellońskie Centrum Rozwoju Leków (JCET)
Voivodeship: małopolskie
Principal investigator (from the host institution)
Number of co-investigators in the project: 2
Call
PRELUDIUM 11 – announced on 2016-03-15
- Amount awarded
- 149 940 PLN
- Project start date
- 2017-02-03
- Project end date
- 2020-02-02
- Project duration
- 36 months (the same as in the proposal)
- Project status
- Project settled
Project description
Download the project description in a pdf file
Note — project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Equipment purchased [PL]
- Laptop. Cost: 3 500 PLN
- Pipeta wielokanałowa. Cost: 4 000 PLN
Information in the final report
Publication in academic press/journals (1)
-
Comparison of Effects of Anti-thrombin Aptamers HD1 and HD22 on Aggregation of Human Platelets, Thrombin Generation, Fibrin Formation, and Thrombus Formation Under Flow Conditions
- Authors:
- Katarzyna Derszniak, Kamil Przyborowski, Karolina Matyjaszczyk, Martijn Moorlag, Bas de Laat, Maria Nowakowska and Stefan Chlopicki
- Academic press:
- Frontiers in Pharmacology (year: 2019, volume: 10, pages: 68), Publisher: Frontiers Media S.A.
- Status:
- Published
- DOI:
- 10.3389/fphar.2019.00068 – link to the publication